Single dose immunoglobulin therapy for childhood Guillain-Barre syndrome

Brain and Development

Volumn 19, Issue 5, 1997, Pages 323-325

  Zafeiriou, Dimitrios I ^a,b   Kontopoulos, Eleutherios E ^a   Katzos, George S ^a   Gombakis, Nikos P ^a   Kanakoudi, Florence G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

Childhood; Guillain barre; Intravenous immunoglobulin (IVIG); Single dose

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; DRUG EFFICACY; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOBILIZATION; RELAPSE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; POLYRADICULONEUROPATHY;

EID: 0030879187     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(97)00024-7     Document Type: Article

References (16)

1. Jones HR Jr. Guillain-Barré syndrome: clinical presentation, diagnosis, and therapy. J. Child. Neurol. 1996; 11: 4-12.
2. van der Meche FGA, Schimitz PIM, Dutch Guillain-Barré Syndrome Study Group. A randomised trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N. Engl. J. Med. 1992; 326: 1123-1129.
3. Shahar E, Murphy EG, Roifman CM. Benefit of intravenously administered immune serum globulin in patients with Guillain Barré syndrome. J. Pediatr. 1990; 116: 141-144.
4. Rajah A. The use of high-dose intravenous immunoglobulins in Guillain-Barré syndrome. Anaesthesia 1992; 47: 220-222.
5. Notarangelo LD, Duse M, Tiberti S et al. Intravenous immunoglobulin in two children with Guillain-Barré syndrome. Eur. J. Pediatr. 1993; 152: 372-374.
6. Vallee L, Dulac O, Nuyts JP, Leclerc F, Vamecq J. Intravenous immune globulin is also an efficient therapy of acute Guillain-Barré syndrome in affected children. Neuropediatrics 1993; 24: 235-236.
7. McGhee W, Jarjour IT. Single-dose intravenous immune globulin for treatment of Guillain-Barré syndrome. Am. J. Hosp. Pharm. 1994; 51: 97-99.
8. Al-Quadah AA. Immunoglobulins in the treatment of Guillain-Barré syndrome in early childhood. J. Child. Neurol. 1994; 9: 178-180.
9. Gurses N, Uysal S, Islek I, Kalayci AG. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Scand. J. Infect. Dis. 1995; 27: 241-243.
10. Nicolaides P, Appleton RE. Immunoglobulin therapy in Guillain-Barré syndrome in children. Dev. Med. Child. Neurol. 1995; 37: 1110-1114.
11. Ganesan V, Kirkham FJ. Immunoglobulin therapy in Guillain-Barré syndrome in children. Dev. Med. Child. Neurol. 1996; 38: 371-373.
12. Constantopoulos A, Langona E. Intravenous immune globulin in children with Guillain-Barré syndrome. Neuropediatrics 1994; 25: 165.
13. Vajsar J, Sloane A, Wood E, Murphy EG. Plasmapheresis vs intravenous immunoglobulin treatment in childhood Guillain-Barré syndrome. Arch. Pediatr. Adolesc. Med. 1994; 148: 1210-1212.
14. Korinthenberg R, Schulte-Moenting J. Natural history and treatment effects in Guillain-Barré syndrome: a multicenter study. Arch. Dis. Child. 1996; 74: 281-287.
15. McKhann GM, Griffin JW, Cornblath DR, Mellits ED, Fisher R, Quaskey SA, Guillain-Barré Syndrome Study Group. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann. Neurol. 1988; 23: 347-353.
16. Rantala H, Uhari M, Cherry JD, Shields WD. Risk factors of respiratory failure in children with Guillain-Barré syndrome. Pediatr. Neurol. 1995; 13: 289-292.